Kaléo

AUVI-Q® (epinephrine injection, USP) is only approved for sale in the U.S.

AUVI-Q is designed to be easy to use and to carry for whoever may be called upon to use it with innovative features like voice instructions, an auto-retractable needle and a pocket-sized design.

AUVI-Q is available in 3 dosages
     • 0.1 mg – the first and only FDA approved epinephrine auto-injector for infants and toddlers
       weighing 16.5-33 lbs
     • 0.15 mg – for children weighing 33 to 66 lbs
     • 0.3 mg – for anyone weighing 66 lbs or more

E-prescribing AUVI-Q is easy – in your EMR select ASPN for home delivery or send the prescription to your
patient’s preferred Walgreens location. See detailed prescribing instructions at https://www.auviq.com/hcp/prescribing.

Patients should seek emergency medical care after using AUVI-Q. To minimize the risk of injection-related
injury, instruct caregivers to hold a young child’s or infant’s leg firmly in place when administering AUVI-Q.
Visit auvi- q.com/important-safety-information to see the full AUVI-Q Indication and Important Safety
Information.